Stockscreener 앱 받기
0.00
100.00%
-0.765
전일 마감가:
$0.765
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$3.71M
수익:
-
순이익/손실:
-
주가수익비율:
0.00
EPS:
-0.604
순현금흐름:
-
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$3.59
Genetic Technologies Ltd Adr Stock (GENE) Company Profile
Genetic Technologies Ltd Adr 주식(GENE)의 최신 뉴스
Genetic Technologies faces NASDAQ equity shortfall - Investing.com India
Genetic Technologies joins "CancerIQ" platform - Investing.com
Genetic Technologies faces Nasdaq noncompliance issue - Investing.com
Genetic Technologies faces Nasdaq noncompliance issue By Investing.com - Investing.com UK
Genetic Technologies launches geneType on EasyDNA platform - Investing.com
Ascendis Pharma (ASND) Surges 8.7%: Is This an Indication of Further Gains? - Yahoo Finance
Genetic Technologies sets sights on U.S. market growth - Investing.com India
Genetic Technologies names new CFO and Company Secretary - Investing.com India
Genetic Technologies Ltd. ADR (GENE) Stock: A Year of Market Fluctuations - The InvestChronicle
Genetic Technologies CFO Steps Down By Investing.com - Investing.com India
HEICO shares target raised, keeps Buy rating on strong outlook By Investing.com - Investing.com India
Barclays maintains FedEx overweight rating, $350 target By Investing.com - Investing.com
Energizer stock PT raised to $375 at Deutsche Bank, reflecting revenue growth By Investing.com - Investing.com
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease - GlobeNewswire Inc.
Genetic Technologies to Host Investor Webinar By Investing.com - Investing.com India
Mastercard shareholders vote on board, executive pay, and proposals By Investing.com - Investing.com
Insmed shares target lifted by Evercore ISI on brensocatib optimism By Investing.com - Investing.com UK
Inozyme Pharma reports voting results, re-elects directors By Investing.com - Investing.com
BM Technologies reports annual meeting results By Investing.com - Investing.com
Gilead's HIV prevention trial shows promise with zero infections By Investing.com - Investing.com
FSN E-commerce stock upgraded by ICICI Securities citing growth focus By Investing.com - Investing.com
Crest Nicholson shares target reduced by Deutsche Bank, margin pressures cited By Investing.com - Investing.com
Biomea Fusion stock downgraded at Barclays; price target slashed to $5 from $30 By Investing.com - Investing.com UK
Genetic Technologies Ltd. ADR (GENE) Stock: A Comprehensive 52-Week Review - The InvestChronicle
The Psychology of Genetic Technologies Ltd. ADR Inc. (GENE) Price Performance: Understanding Market Sentiment - The InvestChronicle
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid ... - Investing.com UK
Li-Cycle holdings director Mark Wellings sells shares worth over $36,000 - Investing.com
Hesai Group CFO Louis T. Hsieh steps down By Investing.com - Investing.com
GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. ... - The Globe and Mail
GMAB: 3 Biotech Stocks Gaining Altitude and Interest - StockNews.com
The 8 Best Penny Stocks On Webull (June 2024) - The Stock Dork
The Best Biotech Stocks to Buy - Morningstar
6 Best Genomics Stocks to Buy in 2024 - The Motley Fool
GMAB: Bank on the Future Returns With These 3 Biotech Stocks - StockNews.com
TEVA: 3 Smart Pharma Picks Serving Gains - StockNews.com
Biotech Stocks, Pharma Heat Up In 2024 As Buyouts, Obesity And AI Drive Excitement - Investor's Business Daily
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change - Yahoo Finance
GSK: 3 Pharma Stocks Flashing 'Buy' Signals in December - StockNews.com
Top 5 NASDAQ Genetics Stocks - Investing News Network
GSK: 3 Pharma Stocks on the RiseIt's Time to Buy Now - StockNews.com
A pharmacogenetic study of perampanel: association between rare variants of glutamate receptor genes and outcomes - Frontiers
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it - Stockhead
Gene Slade’s Journey in Mastering Sales and Transforming Businesses - CEOWORLD magazine
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money ... - Stockhead
Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger - Stockhead
The 20 European Biotech Companies to Watch in 2022 - Labiotech.eu
Syncona to acquire Applied Genetic Technologies Corporation - BioPharma-Reporter.com
Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities? - Stockhead
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Start of demonstration experiment of algal breeding technology to solve climate change issues -Aiming to establish the world's first useful algae breeding technology by introducing genetic mutation through neutron irradiation- - NTT
Tech - GSK
Genetic Technologies Ltd Adr (GENE) 재무 분석
Genetic Technologies Ltd Adr (GENE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.48%
0.04%
자본화:
|
볼륨(24시간):